Skip to main content
SpringerLink
Log in

Alemtuzumab/busulfan/fludarabine

Sarcoidosis (first report with alemtuzumab and busulfan): 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Gooneratne L, Lim ZY, du Vivier A, Salisbury JR, Knisely AS, Ho AYL, Pagliuca A, Mufti GJ.Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation. Bone Marrow Transplantation 39: 511-512, No. 8, 2 Apr 2007 - England

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alemtuzumab/busulfan/fludarabine. React. Wkly. 1156, 6 (2007). https://doi.org/10.2165/00128415-200711560-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711560-00018

Keywords

Search

Navigation